ArticleBMJ open2025

Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study.

Marcus Cumberbatch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.